Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jul 9:3:245.
doi: 10.3389/fphys.2012.00245. eCollection 2012.

Effects of n-3 Polyunsaturated Fatty Acids on Cardiac Ion Channels

Affiliations

Effects of n-3 Polyunsaturated Fatty Acids on Cardiac Ion Channels

Cristina Moreno et al. Front Physiol. .

Abstract

Dietary n-3 polyunsaturated fatty acids (PUFAs) have been reported to exhibit antiarrhythmic properties, and these effects have been attributed to their capability to modulate ion channels. In the present review, we will focus on the effects of PUFAs on a cardiac sodium channel (Na(v)1.5) and two potassium channels involved in cardiac atrial and ventricular repolarization (K(v)) (K(v)1.5 and K(v)11.1). n-3 PUFAs of marine (docosahexaenoic, DHA and eicosapentaenoic acid, EPA) and plant origin (alpha-linolenic acid, ALA) block K(v)1.5 and K(v)11.1 channels at physiological concentrations. Moreover, DHA and EPA decrease the expression levels of K(v)1.5, whereas ALA does not. DHA and EPA also decrease the magnitude of the currents elicited by the activation of Na(v)1.5 and calcium channels. These effects on sodium and calcium channels should theoretically shorten the cardiac action potential duration (APD), whereas the blocking actions of n-3 PUFAs on K(v) channels would be expected to produce a lengthening of cardiac action potential. Indeed, the effects of n-3 PUFAs on the cardiac APD and, therefore, on cardiac arrhythmias vary depending on the method of application, the animal model, and the underlying cardiac pathology.

Keywords: arrhythmias; atrial fibrillation; heart failure; n−3 PUFAs.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Structure of the main n3 (EPA, DHA, and ALA), n6 (AA and LA), monounsaturated (OA), and saturated (SA and PA) PUFAs present in the human diet. Taken from the free ChemSpider Database (http://www.chemspider.com/).
Figure 2
Figure 2
Cardiac AP, ionic currents involved in its genesis and maintenance, and the effects of n3 PUFAs on each current under acute and chronic conditions. ↑, Increase; ↓, decrease; or ∼, no changes in the current amplitude. *Studied in human atria. ?, Not tested. With permission from Ravens and Cerbai (2008).

Similar articles

Cited by

References

    1. Bannenberg G., Serhan C. N. (2010). Specialized pro-resolving lipid mediators in the inflammatory response: an update. Biochim. Biophys. Acta 1801, 1260–1273 - PMC - PubMed
    1. Basiouni S., Stockel K., Fuhrmann H., Schumann J. (2012). Polyunsaturated fatty acid supplements modulate mast cell membrane microdomain composition. Cell. Immunol. 275, 42–4610.1016/j.cellimm.2012.03.004 - DOI - PubMed
    1. Behrens S., Li C., Franz M. R. (1997). Effects of myocardial ischemia on ventricular fibrillation inducibility and defibrillation efficacy. J. Am. Coll. Cardiol. 29, 817–82410.1016/S0735-1097(96)00571-2 - DOI - PubMed
    1. Billman G. E., Kang J. X., Leaf A. (1997). Prevention of ischemia-induced cardiac sudden death by n-3 polyunsaturated fatty acids in dogs. Lipids 32, 1161–116810.1007/s11745-997-0149-2 - DOI - PubMed
    1. Billman G. E., Kang J. X., Leaf A. (1999). Prevention of sudden cardiac death by dietary pure omega-3 polyunsaturated fatty acids in dogs. Circulation 99, 2452–245710.1161/01.CIR.99.18.2452 - DOI - PubMed